In NSCLC, cooperation between cyclin D1 and KRAS was suggested though the involvement of the activated extracellular signal-regulated kinase (ERK)/cyclin D1 pathway in KRAS-driven lung tumorigenesis [48]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.